Evidence map›Paper›PMID 21081748›Full record

ArticleCirculation. Cardiovascular quality and outcomes2010

Variation in recovery: Role of gender on outcomes of young AMI patients (VIRGO) study design.

Judith H Lichtman, Nancy P Lorenze, Gail D'Onofrio, John A Spertus, Stacy T Lindau, Thomas M Morgan, Jeph Herrin, Héctor Bueno, Jennifer A Mattera, Paul M Ridker and 1 more

Abstract read
In one paragraph

Article in Circulation. Cardiovascular quality and outcomes, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Observational
  17. Article
  18. Article
  19. Observational
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Judith H LichtmanDepartment of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT, USA. judith.lichtman@yale.edu
Nancy P Lorenze
Gail D'Onofrio
John A Spertus
Stacy T Lindau
Thomas M Morgan
Jeph Herrin
Héctor Bueno
Jennifer A Mattera
Paul M Ridker
Harlan M Krumholz

Funding

YALE UNIVERSITY CLINICAL AND TRANSLATIONAL SCIENCE AWARD PROGRAMUL1RR024139 · NCRR · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2006 to 2011
$56.8M
Young Women With Acute Myocardial InfarctionR01HL081153 · NHLBI · YALE UNIVERSITY · PI KRUMHOLZ, HARLAN MARC · 2007 to 2012
$10.6M
Sexuality, Aging and Heart Disease: Translating from Population to PatientK23AG032870 · NIA · UNIVERSITY OF CHICAGO · PI LINDAU, STACY TESSLER · 2009 to 2012
$747k
NCRR NIH HHS UL1 RR024139NHLBI NIH HHS R01 HL081153NHLBI NIH HHS R01 HL081153-01A1KNIA NIH HHS K23 AG032870NIA NIH HHS K23AG032870-01A
6 · The paper itself

Abstract

backgroundAmong individuals with ischemic heart disease, young women with an acute myocardial infarction (AMI) represent an extreme phenotype associated with an excess mortality risk. Although women younger than 55 years of age account for less than 5% of hospitalized AMI events, almost 16 000 deaths are reported annually in this group, making heart disease a leading killer of young women. Despite a higher risk of mortality compared with similarly aged men, young women have been the subject of few studies. METHODS AND

resultsVariation in Recovery: Role of Gender on Outcomes of Young AMI Patients (VIRGO) is a large, observational study of the presentation, treatment, and outcomes of young women and men with AMI. VIRGO will enroll 2000 women, 18 to 55 years of age, with AMI and a comparison cohort of 1000 men with AMI from more than 100 participating hospitals. The aims of the study are to determine sex differences in the distribution and prognostic importance of biological, demographic, clinical, and psychosocial risk factors; to determine whether there are sex differences in the quality of care received by young AMI patients; and to determine how these factors contribute to sex differences in outcomes (including mortality, hospitalization, and health status). Blood serum and DNA for consenting participants will be stored for future studies.

conclusionsVIRGO will seek to identify novel and prognostic factors that contribute to outcomes in this young AMI population. Results from the study will be used to develop clinically useful risk-stratification models for young AMI patients, explain sex differences in outcomes, and identify targets for intervention.

Indexed as

Sex FactorsAdolescentAdultBiomarkersEpidemiologic Research DesignFemaleHospitalizationHumansMaleMiddle AgedMyocardial InfarctionPrognosisRiskSurvival AnalysisTreatment OutcomeBiomarkers

Identifiers

PMID21081748
PMCPMC3064946

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.